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Globin Gene Expression Is Reprogrammed
in Chimeras Generated by Injecting Adult
Hematopoietic Stem Cells into Mouse Blastocysts
with multilineage potential and cells able to repopulate
embryonic and neonatal recipients in the long term
(Weissman et al., 1977; Huang and Auerbach, 1993; Pa-
lacios and Imhof, 1993; Yoder et al., 1997). At present,
the direct lineage relationships between the yolk sac±
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is uncertain. At late day 10 of gestation, colony formingUniversitaÈ t Freiburg
units-spleen (CFU-S) and, at day 11 of gestation, HSCs79104 Freiburg
can be detected in the fetal liver (Medvinsky et al., 1993;Germany
MuÈ ller et al., 1994). After day 15 of gestation, hematopoi-
esis begins in the fetal spleen and bone marrow.
At each progressive developmental stage, differentSummary
as well as overlapping subsets of mature hematopoietic
cells are produced (for review, see Bonifer et al., 1998).To elucidate whether the differentiation capacity of
For instance, yolk sac hematopoiesis produces mostlyhematopoietic stem cells (HSCs) is influenced by spe-
primitive erythroid cells that are large and nucleated. Incific microenvironments, adult mouse bone marrow±
contrast, the definitive erythroid cells of the adult bonederived HSCs were injected into mouse blastocysts.
marrow are smaller and enucleated (Russell, 1979). Fur-Embryos developing from injected blastocysts con-
ther examples of ontogenic-specific subset differencestained donor-derived cells at various developmental
in the hematopoietic system are B1a (CD51) B cells,stages, and progeny of the stem cells were detected
which areproduced predominantly from progenitor cellsin hematopoietic tissues. Thus, HSCs derived from an
present in the fetal liver; Vg31 and Vg41 T cells, which areadult animal survive after injection into blastocysts
generated by fetal liver, not bone marrow,hematopoieticand are able to participate in hematopoietic devel-
stem cells (Herzenberg et al., 1992); and embryonic/fetalopment. We further find that the erythroid progeny
versus adult-type macrophages (Faust et al., 1997). Theof transplanted adult HSCs express embryonic/fetal-
basis for the differences in the developmental potentialtype globin genes and, conversely, that embryonic and
of embryonic, fetal, and adult hematopoietic systems isfetal progenitor cells transplanted into adult recipients
unclear.transcribe the adult-type globin gene. Thus, the de-
The generation of different mature hematopoietic cellvelopmental potential of adult HSCs is evidently more
subsets is reflected on the molecular level by develop-plastic than previously thought, and the develop-
mental stage±specific and cell lineage±specific gene ex-mental stage of the hematopoietic microenvironment
pression. The best studied model in this respect is pro-controls the developmental fate of transplanted pro-
vided by the members of the b-globin gene family, whichgenitor cells.
are regulated in a tissue-specific and developmentally
specific manner. A fundamental question is to what ex-Introduction
tent theswitches in globin gene expression are the result
of interactions of hematopoietic cells with specific mi-
During development of the vertebrate hematopoietic
croenvironments or are intrinsic to the hematopoietic
system, progenitor and stem cells are found in different
cells. Transplantation of fetal hematopoietic cells into
locations of the embryo (Metcalf and Moore, 1971). Dur-
immune-ablated adult recipients leads to a switch from
ing mouse ontogeny, the first cells of hematopoietic fetal to adult-type globin gene expression (Mouchiroud
origin can be seen on day 7 of gestation in the blood
and Blanchet, 1981), indicating that the adult microenvi-
islands that arise in the extraembryonic mesoderm of
ronment is able to control the differentiation program
the yolk sac. The definitive hematopoietic system is
of fetal hematopoietic progenitor cells. In contrast, adult
thought to be initiated by intraembryonic precursor cells HSCs are unable to produce fetal-type T cells following
located in the paraaortic splanchnopleura, which later the injection into fetal thymic lobes, suggesting that fetal
develops into the aortic-gonad-mesonephros (AGM) re- liver stem cells have an intrinsically different develop-
gion (Godinet al.,1993; Medvinsky et al., 1993). Hemato- mental potential than adult bone marrow stem cells
poietic stem cell activity is found in the AGM region at (Ikuta et al., 1990).
late day 10 of gestation before the appearance of liver This apparent difference in thedifferentiation potential
stem cell activity (MuÈ ller et al., 1994). Multipotent hema- of fetal and adult HSCs can be explained by two models.
topoietic progenitors and stem cells capable of long-term (1) HSCs mature during ontogeny and irreversibly alter
repopulation of adult recipient mice originate autono- their differentiation potential. This would lead to an in-
mously in the splanchnopleuric mesoderm/AGM region ability of adult HSCs to resume the embryonic or fetal
of the embryo (Cumano et al., 1996; Medvinsky and gene expression pattern when placed in an embryonic
Dzierzak, 1996). Additionally, the yolk sac contains cells or fetal microenvironment, in contrast to fetal HSCs,
which still have the potential to switch to the adult pro-
gram. (2) HSCs must undergo a defined sequence of³To whom correspondence should be addressed.
cell±cell interactions in order to determine their differen-§Present address: University of Leeds, Molecular Medicine Unit, St.
James University Hospital, Leeds LS9 7TF, United Kingdom. tiation potential.
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Figure 1. Experimental Strategy
Injection of hematopoietic progenitor and stem cells into preimplantation blastocysts (A) and adult recipients (B). Hematopoietic stem cells
were isolated from adult bone marrow as described (Okada et al., 1992). After the injection of stem cells into blastocysts, the growth potential
of the stem cells was determined either by growing the blastocysts in vitro in methylcellulose cultures or, alternatively, by retransplantation
into pseudopregnant foster mothers. Chimerism was analyzed on genomic DNA by donor-specific PCR, and the developmental stage±specific
gene expression pattern of the donor cells was analyzed by RT±PCR with PCR primers specific for human e-, g-, or b-globin messages
(Bungert et al., 1995) in cases where HSCs from human globin transgenic animals were injected (Strouboulis et al., 1992). (B) Generation of
CFU-S from tissues of different developmental stages. Single-cell suspensions of tissues from human b-globin transgenic embryos were
intravenously injected into lethally irradiated recipients, and individual spleen colonies were isolated on the eighth and eleventh day postinjec-
tion. DNA and RNA from individual colonies were prepared for the analysis of donor origin and transcription of individual human b-globin
transgenes.
Experiments aimed at solving the question of whether new experimental approach, we demonstrate a domi-
nance of the developmental stage of the microenviron-HSCs from the adult animal retain plasticity therefore
require the transplantation of HSCs into very early em- ment over the developmental stage of the injected he-
matopoietic stem cells.bryos that have not yet developed a hematopoietic mi-
croenvironment. Transplantations of yolk sac, fetal liver,
and bone marrow cells into midgestation mouse em- Results
bryos in the yolk sac cavity and via the placenta (Fleisch-
man and Mintz, 1984; Toles et al., 1989) showed that Hematopoietic Stem Cells Generate Chimeric
Embryos Following Injection into Blastocystsheterochronically injected hematopoietic cell popula-
tions can form an adult chimeric hematopoietic system. In order to analyze the differentiation potential of HSCs
exposed to varying microenvironments present at differ-However, these chimeric animals were not examined at
embryonic stages for developmentally specific hemato- ent developmental stages of the embryo, we trans-
planted HSCs into the earliest developmental stagespoietic gene expression or subset generation by donor
cells. allowing such manipulations. Since HSCs migrate dur-
ing ontogeny to different hematopoietic tissues and thusTo test whether interactions between the hematopoi-
etic microenvironment and the stem cell population play come in contact with various microenvironments, we
speculated that this particular cell type might be suiteda role in the regulation of gene transcription and in the
generation of certain subsets of hematopoietic cells, to survive in the microenvironment provided by the early
stage embryo. We thus injected a limited number ofwe exposed adult bone marrow±derived HSCs to an
embryonic microenvironment by injection into preim- adult bone marrow cells with the Lin2, c-kit1, Sca-11
cell surface phenotype into blastocysts (Figure 1). Asplantation blastocysts. We demonstrate that HSCs sur-
vive in the blastocyst microenvironment and generate a few as 40 of these sorted cells, when injected into le-
thally irradiated adult recipients, were capable of multi-chimeric hematopoietic system. Using transgenic mice
carrying the complete human b-globin gene locus, we lineage and long-term repopulation (data not shown).
Of the blastocysts injected with 10±40 purified HSCsshow that progeny of the adult HSCs resume the embry-
onic gene transcription pattern while in an embryonic and cultured in methylcellulose supplemented with he-
matopoietic growth factors, 24 of 27 supported the de-environment. Furthermore, we show that embryonic he-
matopoietic progenitors activate adult-type genes fol- velopment of hematopoietic colonies, whereas no colo-
nies developed in 15 noninjected blastocysts culturedlowing the transplantation into adult recipients. With this
Reprogramming of HSCs by Injection into Blastocyst
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Figure 2. In Vitro Colony Formation of Hema-
topoietic Stem Cells Injected into Blastocysts
HSCs from C57BL/6 mice were injected into
BALB/c blastocysts. Injected (A±C) and non-
injected (D) blastocysts were maintained in
liquid culture for 1 day and in methylcellulose
supplemented with hematopoietic growth
factors for 9 days thereafter. Photos are rep-
resentative. Magnification: 1003.
under the same conditions (Figure2). Mostly mixed colo- liver, and peripheral blood (Figure 3C). Detection of male
sequences in DNA prepared from the bone marrow, butnies developed from injected blastocysts after dis-
not in other tissue, including thymus and spleen, of anpersal, similar to colonies growing in cultures directly
adult female recipient animal (Figure 4), demonstratedseeded with sorted HSCs. The former form on average
that donor-derived hematopoietic cells can survive theabout 7 colonies per 100 injected HSCs, whereas the
entire ontogeny.latter generate about 18 colonies per 100 HSCs. The
The cumulative transplantation results of 10 indepen-reduction in colony numbers is most likely due to the
dent HSC preparations injected into 53 recipients aremanipulations needed to generate single cell suspen-
summarized in Table 1. A high percentage of embryossions. Our data show that the blastocyst microenviron-
contained donor-derived cells. However, the frequencyment is not lethal for adult HSCs.
of successful repopulation appeared to decrease withTo follow the fate of donor HSCs in embryos and
the age of the recipient. Most E11.5 embryos showedadults derived from reimplanted blastocysts, HSCs car-
donor cells in yolk sac, fetal liver, and blood, whereasrying distinct genetic markers suitable for detection by
at day E16.5 only 50% of the analyzed yolk sacs andsemiquantitative PCR were used for injection. To this
none of the fetal livers or heads containeddonor-derivedend, male HSCs were injected into blastocysts and
cells. Interestingly, the tissue most extensively repopu-female embryos were assayed with Y-chromosome-
lated varied during the development of the chimericspecific polymerase chain reaction (PCR) primers (sry
mice. In 7 of 8 E11.5 embryos, the fetal liver contained
[MuÈ ller et al., 1994] or YMT2/B [Medvinsky and Dzier- the highest percentage of donor cells, whereas from
zak, 1996]). Alternatively, HSCs transgenic for human
day E13.5 to E16.5 the yolk sac revealed the highest
b-globin (Strouboulis et al., 1992) or a lacZ transgene contribution in most embryos (data not shown). Only 2
(Friedrich and Soriano, 1991) were injected into blas- of 9 adult mice were repopulated in the bone marrow,
tocysts from nontransgenic mice. All PCR reactions and donor contribution in embryonic and adult tissues
included primers specific for the myogenin gene as in- was on average less than 2%. However, this donor con-
ternal PCR controls (MuÈ ller et al., 1994). Analysis of tribution in individual embryos was assessed on geno-
hematopoietic tissues (yolk sac and fetal liver) and a mic DNA prepared from the yolk sac and fetal liver,
nonhematopoietic tissue (head) of female embryos at which are only partly composed of hematopoietic cells,
embryonic day 11.5 (E11.5) and E15.5 derived from blas- so that there is an underestimation of the contribution
tocysts injected with male HSCs (Figures 3A and 3B) to the hematopoietic system. In terms of repopulation
revealed donor-derived signals preferentially in hemato- levels, we found no significant differences between
poietic tissues. Genomic Southern blot analysis indi- HSCs injected into C57Bl/6, BALB/c blastocysts or
cated that fetal liver of embryo 3 was approximately into Wv/Wv, Wv/1, and wild-type blastocysts (data not
10% chimeric for the progeny of the injected male HSCs shown). These data demonstrate that donor-derived he-
(data not shown). E13.5 embryos derived from blasto- matopoietic cells can survive the entire ontogeny and
cysts injected with HSCs transgenic for human b-globin that the injected stem cells or progeny thereof are found
at the sites where hematopoiesis occurs.revealed human b-globin sequences in yolk sac, fetal
Cell
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Figure 3. Donor Contribution in Chimeric Re-
cipients Following the Injection of HSCs into
Blastocysts
Genomic DNA was prepared from embryos
at different gestational ages: (A) E11.5 days
(embryo 3) and E15.5 days (embryos 5±7),
and (B) E15.5 days (embryos 9±12). Chimeric
embryos were derived following the injection
of male C57BL/6 HSCs into BALB/c mouse
blastocysts. Before analyzing donor contri-
bution, male embryos were excluded by
YMT2/B- and myogenin-driven PCR on geno-
mic head DNA. Male donor cell contribution
in female embryos was assessed semiquanti-
tatively using Y-chromosome-specific prim-
ers (YMT2/B) in combination with myogenin-
specific primers as normalization controls.
Donor contributions was determined by PCR
on male genomic DNA diluted in female geno-
mic DNA (total of 200 ng). Dilutions are as
indicated (100%, 20%, 2%, 0.2%, and 0%
male contribution). (C) HSCs from human
b-globin transgenic mice were injected into
BALB/c mouse blastocysts. Chimeric em-
bryos 62 and 63 were analyzed at gestational
age E13.5. Genomic DNA samples of recipi-
ents were analyzed for donor contribution
by human b-globin/myogenin-specific PCR.
Controls are 100%, 20%, 2%, 0.2%, and 0%
genomic DNA from human b-globin trans-
genic mice diluted in nontransgenic DNA.
Autoradiograms of the Southern blots are
shown. Abbreviations are as follows: YS, yolk
sac; FL, fetal liver; He, head; HL, hind limbs;
PB, embryonic peripheral blood.
Donor-Derived Hematopoietic Progenitor circulation were cultured for 16 days in methylcellulose
containing G418 plus hematopoietic growth factors.Cells Can Be Detected in the Fetal Liver
and Embryonic Circulation When cells from fetal liver or embryonic circulation of
E12.5 embryos derived from the injection of HSCs intoThe successful engraftment of hematopoietic tissues
after the injection of hematopoietic stem cells into blas- blastocysts were cultured under G418 selection, no nor-
mal-sized colonies were obtained. We did see, however,tocysts led to experiments testing whether donor-
derived hematopoietic progenitor cells could be de- numerous small colonies with myeloid morphology. PCR
analysis of genomic DNA prepared from individual smalltected by hematopoietic colony formation in semi-solid
media in the presence of appropriate growth factors. colonies arising from 17 fetal livers showed that 16 of
138 G418-resistant colonies were positive for the lacZThe mouse strain ROSAb-geo26 (Friedrich and Soriano,
1991), which carries a neomycin phosphotransferase marker (Figure 5). In addition, we performed further col-
ony assays to test for the presence of donor-derivedand lacZ (b-geo) fusion transgene, was used as a source
of HSCs to distinguish endogenous from donor-derived hematopoietic progenitors in the embryonic circulation
and found 2 colonies positive for the lacZ transgenehematopoietic progenitor cells. HSCs from ROSAb-
geo26 mice were isolated and injected into blastocysts, among 150 colonies tested from 20 individual E12.5 em-
bryos. Since only hematopoietic colonies grow underand at day E12.5 cells from fetal liver and embryonic
Figure 4. Long-Term Engraftment of Adult
Recipients after Injection of Adult HSCs into
Blastocysts
C57BL/6-derived adult HSCs from male ani-
mals were injected into BALB/c blastocysts.
Female recipients were sacrificed at 8 weeks
of age. Genomic DNA was prepared and do-
nor male cell contribution was assessed as
described in Figure 3. Abbreviations for the
analyzed tissues are as follows: S, spleen;
BM, bone marrow; Th, thymus; Mu, muscle;
Br, brain.
Reprogramming of HSCs by Injection into Blastocyst
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Table 1. In Vivo Analysis of HSCs Injected into Blastocysts
Age of Recipients Tissue Analyzed (Positive/Total)
Analyzed
Emb.
YS FL Head Limbs Blood
E11.5 7/8 8/8 4/17 2/2 5/10
E12.5 3/9 2/9 2/9 ND 3/5
E13.5 6/7 2/7 0/7 1/3 2/3
E15.5 6/6 4/6 0/5 ND ND
E16.5 3/6 0/6 0/6 1/3 1/3
Adult BM Thy Spl Mu Br
Figure 5. In Vitro Differentiation of Hematopoietic Progenitors from
2/9 0/9 0/9 0/5 0/6
Chimeric Fetal Livers
Blastocysts were from strains BALB/c (40 embryos developing from PCR analysis for the presence of the lacZ transgene was performed
injected blastocysts), C57BL/6 (4 embryos developing from injected on methylcellulose colonies grown from noninjected (embryo 135)
blastocysts), or from matings of Wv/1 animals (9 embryos were and chimeric fetal livers (embryos 137±139) after selection in the
analyzed: 1 wild-type, 4 Wv/1 and 4 Wv/Wv animals). HSCs were presence of G418 for 16 days. Chimeric fetal livers were isolated
isolated from C57BL/6, ROSAb-geo26 (Friedrich and Soriano, 1991), from E12.5 embryos derived from the injection of ROSAb-geo26
and human b-globin transgenic mice (line 72, [Strouboulis et al., bone marrow cells into blastocysts. The blastocysts are from mat-
1992] backcrossed to C57BL/6). Donor contribution was tested by ings of Wv/1 animals (embryos 137 [1/1], 138 [Wv/Wv], and 139
PCR with one or more of the following PCR combinations: sry/ [Wv/1]). Individual colonies (.50 cells) were isolated (a-d), DNA was
myogenin (MuÈ ller et al., 1994), YMT2/B/myogenin (Medvinsky and prepared, and PCR was performed with primers specific for the
Dzierzak, 1996), human b-globin/myogenin, or lacZ/myogenin prim- lacZ transgene carried by ROSAb-geo26-derived cells. DNA from
ers. Abbreviations: YS, yolk sac; FL, fetal liver; emb. blood, embry- ROSAb-geo26 bone marrow and DNA from a ROSAb-geo26 colony
onic blood; BM, bone marrow; Thy, thymus;Spl, spleen; Mu, muscle; derived from an adult bone marrow progenitor cell were analyzed
Br, brain; ND, not determined. as controls.
6A, embryo 146; data not shown), indicating the pres-
ence of a fetal-type gene transcription pattern. Injectionthese conditions, this shows that donor-derived myeloid
of HSCs from male and human globin transgenic miceprogenitor cells are present in the E12.5 embryo in the
enabled us to analyze donor contribution on the DNAfetal liver and circulation.
and RNA level (Figure 6B). Using male (YMT/myogenin)
and human b-globin-specific PCR primers on genomic
DNA, we find donor-derived cells in different tissues ofAdult HSCs Resume Embryonic/Fetal globin Gene
Expression after Injection into Preimplantation E11.5 embryos 54 and 57. Donor cells are present in
yolk sac, fetal liver, head, and hind limbs in embryo 54Blastocysts in Erythroid Progeny
In order to test whether an embryonic differentiation and in yolk sac, fetal liver, head, and peripheral blood
of embryo 57. Expression of human globin transgenesprogram is activated or an adult program is maintained
in donor-derived cells in developing chimeric embryos, was detected in fetal liver of embryo 54 and fetal liver
and head of embryo 57. Together, the results from thesewe injected purified adult bone marrow±derived hema-
topoietic stem cells from human b-globin transgenic experiments suggest that in an embryonic/fetal micro-
environment, adult HSCs generate progeny that expressanimals into blastocysts. The human b-globin transgene
locus has been shown to be expressed in a tissue- an embryonic/fetal-type gene expression program.
specific and developmental stage±specific manner in
mice (Strouboulis et al., 1992). Detailed analysis of the Embryonic and Fetal CFU-S Produce Progeny
which Activate the Adult-Type Globin Geneexpression pattern of the transgene locus revealed that
the e-globin gene behaves as a purely embryonic gene, Expression Program after Exposure
to the Adult Microenvironmentthe g-globin gene as an embryonic and an early fetal
gene, and the b-globin gene as both fetal- and adult- The above described experiments show the generation
of donor cells expressing the embryonic globin programexpressed gene. Analysis of the transcription pattern of
the transgene locus therefore allows us to distinguish when adult hematopoietic stem cells are placed in an
embryonic microenvironment. To analyze the influencebetween an embryonic, fetal, or adult differentiation pro-
gram in the progeny of the transplanted adult stem cells. of the adult microenvironment on embryonic/fetal pro-
genitor and stem cells, we transplanted single-cell sus-We analyzed 18 E10.5, 7 E11.5, and 41 E12.5 embryos
developing after injection of adult HSCs from human pensions of yolk sac, AGM region, and fetal liver into
irradiated adult hosts for the generation of spleen colo-globin transgenic animals into blastocysts by multiplex
RT±PCR for human globin transcription (Bungert et al., nies (see Figure 1B). Since it has beendemonstrated that
early (CFU-S7±8) and late (CFU-S10±12) represent different1995). An example of such an analysis is depicted in
Figure 6A. In total, we found that 6 out of 18 E10.5 classes of hematopoietic progenitor cells (Magli et al.,
1982), we analyzed CFU-S8 and CFU-S11 for transcriptionembryos, 2 out of 7 E11.5 embryos, and 16 out of 41
E12.5 embryos were transcribing the embryonic human of individual human globin transgenes. Distinct spleen
colonies descending from single progenitors were iso-e- and g-globin transgenes. In two of the analyzed E12.5
embryos, a weak human b-globin signal was detected lated and the expression of individual genes of the hu-
man globin transgene locus was tested by multiplexin addition to human e- and g-globin transcripts (Figure
Cell
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Figure 6. Developmental Stage±Specific Gene Expression in Adult Hematopoietic Stem Cells Following Injection into Blastocysts
Donor-specific RT±PCR and PCR analysis on RNA and DNA of chimeric embryonic tissues. Chimeric embryos were generated by the injection
of male, human globin transgenic HSCs into blastocysts resulting from matings of (A) Wv/1 animals and (B) BALB/c animals. Tissues were
dissected out from E12.5 embryos (embryos 146 [Wv/1 ], 147 [1/1], 173 [1/1], 174 [1/1], and 175 [Wv/Wv]) and E11.5 BALB/c embryos.
Total RNA was prepared from individual tissues and subjected to RT±PCR analysis. Samples were normalized by probing for HPRT expression
and tested for expression of the human globin transgenes by a set of human e-, g-, and b-globin-specific PCR primers ([A and B], top) (Bungert
et al., 1995). cDNAs equivalent to 50 ng of total RNA were used as templates for RT±PCR reactions (embryos 146±175, 54, and 57, and as a
control, E12.5 embryo 236, developing from a noninjected blastocyst). cDNA equivalent to 50 ng noninjected E10.5 embryos; cDNA equivalent
to 0.5 ng transgenic E10.5 yolk sac (YS), E12.5 fetal liver (FL), adult peripheral blood (PB) or adult spleen (Spl); and cDNA equivalent to 0.05
ng (FL1) and 0.005 ng (FL2) transgenic E12.5 fetal liver were used as controls and expression standards. All cDNAs coming from transgenic
embryos were supplemented with cDNA derived from noninjected E10.5 embryos to give 50 ng RNA equivalents. Autoradiograms of polyacryl-
amide gels ([A and B], top) and of Southern blots ([B], bottom) are shown. Donor male- and human globin±specific contributions in genomic
DNA of chimeric embryonic tissues shown ([B], bottom) were done as described in Figure 3. Abbreviations are as follows: YS, yolk sac; FL,
fetal liver; Spl, adult spleen; He, head; n.tg, nontransgenic E10.5 embryo; HL, hind limbs; PB, embryonic peripheral blood.
Reprogramming of HSCs by Injection into Blastocyst
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Figure 7. Developmental Stage±Specific Glo-
bin Gene Expression of Embryonic and Fetal
HematopoieticStem Cells Following the Gen-
eration of CFU-S in Adult Spleens
Shown is the human globin±specific RT±PCR
analysis on RNA of adult bone marrow (BM),
E12.5 fetal liver (FL), E10.5 AGM region
(AGM), and E10.5 yolk sac (YS) derived
CFU-S. Single-cell suspensions from individ-
ual tissues of human globin transgenic ani-
mals were prepared and injected into lethally
irradiated C57Bl/6 recipients. Individual spleen colonies were isolated on the eighth and eleventh day after injection and analyzed for human
b-globin transgene expression. Human e-, g-, and b-globin-specific RT±PCR analysis was done as described in Figure 6. PCR was normalized
for the expression of the adult human b-globin signal.
RT±PCR (2±5 CFU-S8 and 2±8 CFU-S11 were analyzed) could also be involved in HSC development. Members
of the transforming growth factor family of proteins(Bungert et al., 1995). In bone marrow±derived colonies,
only the adult-specific human b-globin mRNA can be (TGFb) like TGFb1 and bone morphogenetic proteins
(BMP), are candidates for growth factors that play a rolefound (Figure 7). CFU-S8 derived from the injection of
E12.5 fetal liver cells, E10.5 AGM region cells, and E10.5 in early embryogenesis as well as in the development
of the hematopoietic system (Dickson et al., 1995; Jo-yolk sac cells also express the adult human b-globin
transgene. However, embryonic-type human e- and hansson and Wiles, 1995).
g-globin mRNAs are also detectable, albeit at a low
level. In contrast, when spleen colonies derived from The Fate of HSCs Introduced
by Blastocyst Injectionembryonic and fetal tissues are isolated on the eleventh
day postinjection (CFU-S11), only the adult human b-glo- Contribution of donor cells did not occur at the same
level in all chimeric embryos analyzed. Although stembin transgene is transcribed. These data indicate that
the microenvironment of the adult spleen changes the cells have the potential to differentiate into several ma-
ture cell lineages, when individual stem cells are ana-developmental stage of embryonic/fetal CFU-S11, caus-
ing them to behave as adult-type progenitor cells, lyzed, they might not show their full capacity. This is
reminiscent of the varying degree of chimerism foundwhereas in some cells found in CFU-S8 the gene expres-
sion pattern of the original developmental stage is still in animals generated by injection of ES cells into blasto-
cysts (Beddington and Robertson, 1989) or by transpla-present.
cental injections of HSCs (Fleischman and Mintz, 1984;
Toles et al., 1989). We observed a decrease in donorDiscussion
contribution with age of the recipient. This decrease is
most likely the result of a competition between injectedGeneration of a Chimeric Hematopoietic System
Following the Injection of Adult HSCs and endogenous HSCs for stem cell niches, since in our
experimental protocol donor HSCs have no selectiveinto Blastocysts
The experiments described here demonstrate that HSCs advantage over endogenous HSCs. In the cases where
HSCs were injected into blastocysts resulting from mat-from the adult mouse are able to generate a chimeric
hematopoietic system when injected into day 3.5 blasto- ings of Wv/1 animals, which are characterized by an
underlying stem cell defect due to a mutation in thecysts. Donor-derived cells were found in hematopoietic
tissues of the embryo, i.e., yolk sac, fetal liver, and pe- c-kit gene, no improvement of donor contribution was
observed. However, so far the numbers of Wv/Wv andripheral blood, as well as in the bone marrow of adult
animals (Figures 3 and 4). Thus, hematopoietic stem Wv/1 recipients analyzed are low. As Wv/Wv and Wv/1
animals are only moderately and slightly anemic, thecells from adult bone marrow are capable of contributing
to the developing embryo. injection of HSCs into blastocysts from more severe
c-kit mutant animals might facilitate donor engraftmentThe generation of chimeric animals by the injection
of HSCs into blastocysts is intriguing, since many cell by overcoming the competition of endogenous HSCs
(Fleischman et al., 1982). Alternatively, the low and de-generations and differentiation stages separate adult
HSCs from cells of the blastocyst. Previously, it was creasing donor contribution during development could
be due to the histoincompatibility of transplanted HSCsshown that while injection of donor cells from the primi-
tive ectoderm of E6 or E7 embryos led to no chimeras, and host blastocysts. When allogeneic cells were intro-
duced into early fetuses via the placental circulation, itinjection of E5 embryonic cells or cultured E8.5 primor-
dial germ cells into blastocysts did produce chimeras was reported that although fully allogeneic cells are able
to seed the host's hematopoietic system, histoincom-(Gardner et al., 1985; Matsui et al., 1992). In contrast
to these data, we were able to generate chimeras by patibility is a limiting factor (Fleischman and Mintz,
1984).injection of cells from an adult animal into blastocysts.
Apparently, both blastocyst and developing embryos An important question is whether HSCs from the adult
bone marrow proliferate in the injected blastocysts orare able to provide an appropriate microenvironment
for the survival of hematopoietic stem cells. It may be only survive until the embryo develops its endogenous
hematopoietic system. If proliferation of stem cells oc-speculated that some of the same factors required for
survival, proliferation, or maturation of embryonic cells curs, it must be very limited considering the confined
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space in the blastocysts and developing embryo. Mas- tissues and adjust their differentiation potential as a
result of the exposure to thechanging microenvironmentsive expansion of the injected stem cells would most
probably affect the development and growth of the in- in the developing embryo (see below).
jected blastocyst. At present it is unclear whether the
injected HSCs maintain the properties of pluripotent
Plasticity in the Differentiation PotentialHSCs in the midgestation and adult chimeric recipients.
of the Adult Hematopoietic ProgenitorTesting for donor-derived hematopoietic stem cell activ-
and Stem Cell Compartmentity at different developmental stages will answer this
Using a transgene marker for the analysis of develop-question.
mental stage±specific gene expression patterns, weWhich hematopoietic cell lineages are generated in
obtained two findings following heterochronic trans-chimeric animals? The detection of human globin±
plantation of hematopoietic progenitor and stem cells.specific RT±PCR signals in chimeric tissues (Figures 6A
First, the injected adult hematopoietic stem cells pro-and 6B) demonstrates the presence of erythroid cells,
duce cells which transcribe the embryonic (e) and fetalwhereas contribution to the myeloid lineage was de-
(g) and, in some chimeric embryos, a combination oftected when cells from chimeric fetal livers were cultured
human embryonic, fetal, and adult b-globin transgenes.in methylcellulose assays (Figure 5). No donor contribu-
Secondly, embryonic and fetal-derived CFU-S, intro-tion was detected in lymphoid organs of adult chimeric
duced into the microenvironment provided by the adultanimals, indicating that the injected HSCs have not con-
spleen, develop into cells expressing the adult b-globintributed to the lymphoid lineage in adult recipients. How-
transgene. These data suggest that the developmentalever, donor-derived lymphoid cells may be present in
age of the microenvironment is dominant over the devel-chimeric fetuses.
opmental stage of the hematopoieticstem cells, and thatThe small size of the methylcellulose colonies could
it determines whether the primitive or definitive erythroidindicate that the injected hematopoietic stem cells have
expression program is displayed. Changes in the devel-either lost proliferative potential or have silenced the
opmental expression pattern of the human b-globinb-geo transgene during the development in the chimeric
transgenes involve the whole transgene locus (Strou-animal. Since fetal HSCs have a higher repopulating
boulis et al., 1992), and this pattern is achieved throughpotential than their adult bone marrow counterparts (Re-
competition of the promoters for the activating functionbel et al., 1996), it will be interesting to determine if
of the locus control region (Hanscombe et al., 1991).hematopoietic stem cells from earlier developmental
Transcriptional activation of the b-globin gene onlystages, like E10.5 AGM region or fetal liver, with a shorter
takes place following the silencing of the e-globin andproliferative history and higher proliferation rate (Lans-
g-globin promoters by changes in the transcription fac-dorp et al., 1994), will improve the extent of hematopoi-
tor composition (Dillon and Grosveld, 1991; Ronchi etetic chimerism.
al., 1996). Our findings indicate that developmentalThe detection of donor signals in tissues where en-
changes in the transcription pattern of embryonic, fetal,dogenous hematopoiesis occurs and endogenous HSCs
and adult erythropoietic systems are influenced by envi-are found (Figures 3 and 4) suggests that the donor
ronmental factors and are not irreversible. However,hematopoietic progenitor and stem cells home to the
from our current data we cannot determine whethersame locations as endogenous hematopoietic stem
heterochronic microenvironments act on the HSCscells. Donor signals detected in head and hind limbs
themselves or on committed erythroid progenitor cells,most likely arise from donor cells in the peripheral blood
as our assay system allows only the detection of genesor hematopoietic cells differentiating into glial cells (Eg-
first transcribed at the proerythroblast stage (Karlssonlitis and Mezey, 1997). The contribution of donor cells
and Nienhuis, 1985).in some cases to hind limb and head (e.g., Figure 6B)
Why do erythroid progeny of the injected stem cellsat levels similar to that of fetal liver suggests that the
resume an embryonic-type transcription pattern afterHSCs have produced myeloid cells, as all three fetal
being transplanted into blastocysts but not after trans-tissues contain macrophages (Morris et al., 1991; Hop-
plantation into midgestational embryos? First, earlierkinson-Woolley et al., 1994), or the donor signals may
reports of heterochronic transplantations into mousecome from erythroid cells in the embryonic circulation.
(Blanchet et al., 1982) and sheep (Zanjani et al., 1982)Another interesting point regards the question of
fetuses were performed with total bone marrow cellswhether our assay selects for a particular type of stem
containing numerous committed erythroid precursorcell. Since the HSC pool is likely to be heterogeneous,
cells instead of purified hematopoietic stem cells. Theremnants of an embryonic/fetal hematopoietic stem cell
control by environmental factors of stage-specific genepopulation may reside in the adult bone marrow (Van
expression programs in already committed progenitorsZant et al., 1997) and retain their potency to take part
might be less plastic than in pluripotent HSCs. Second,in the development of the blastocyst. However, if those
cells transplanted into midgestational embryos maystem cells do exist in the adult bone marrow and if they
have missed a developmental time window within whichare the cells which give rise to the chimeric embryos,
the adultstem cells have tobe exposed to a specific fetalthey must be present in a high frequency within the Lin2,
environment in order to resume a fetal differentiationc-kit1, Sca-11 cell population, given the high rate of
program. Third, we tested for strongly transcribed globinchimerism observed after injecting this cell population
transgenes using RT±PCR, which allows the detectioninto blastocysts. Thus, we regard this possibility as
of minute amounts of mRNA.rather unlikely. We favor instead the hypothesis that
adult HSCs and/or their progeny home to hematopoietic How plastic is the regulation of developmental stage±
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Mannheim), 2% pokeweed mitogen-stimulated murine spleen cell±specific transcription in the hematopoietic progenitor
conditioned medium (PWM-SCCM, StemCell Technologies), 25 U/mland stem cell compartments? Adult HSCs, or progeny
rmIL3 (Boehringer Mannheim), and 1 U/ml rmEPO (Boehringerthereof, can be reprogrammed toactivate an embryonic-
Mannheim). Colony numbers and types were analyzed on single-
type gene expression pattern when in contact with an cell suspensions from injected blastocysts following incubation in
embryonic microenvironment. Similarly, but conversely, Tyrode's acid (Sigma) and trypsin. Cell suspensions were grown in
methylcellulose for 9±15 days in 7.5% CO2 and 5% O2 at 378C.embryonic and fetal CFU-S give rise to progeny tran-
Colony types were determined on cytospins by staining with Diffscribing the adult globin genes in an adult recipient.
Quik (Baxter).We find that embryonic and fetal-derived CFU-S8 still
maintain some embryonic/fetal identity, as indicated
by a low level of embryonic/fetal globin transcription, Embryo Age and Analysis of Donor Contribution
Embryo age was determined starting with 0.5 days on the morningwhile embryonic and fetal CFU-S11 transcribe the adult,
of vaginal plug discovery. Because the development of reimplantednot the embryonic/fetal, globin transgenes. Since it is
blastocysts is significantly delayed and resembles embryos whichthought that CFU-S8 represent more mature progenitors
are 1 day younger, the age of embryos developing from injected
as compared to CFU-S11 (Magli et al., 1982), these data blastocysts was defined as 1 day less than the time of fertilization.
may reflect different degrees of plasticity within the pro- The genotypes of offspring resulting from matings of Wv/1 animals
genitor cell compartment depending on the position of were determined by PCR as described (Tanosaki and Migliaccio,
1997). Semiquantitative PCR was performed on 200 ng of genomica progenitor cell within the hematopoietic hierarchy. It
DNA using transgene-specific primers for the lacZ gene (59-CTAis possible that the more immature a cell is, the more
GAC TGA CAT GGC GGA TC-39 and 59-GTG GGA ACA AAC GGCplastic is its character.
GGA TT-39), human b-globin (59-CAC AGT CTG CCT AGT ACA TTA
In summary, we have shown that adult HSCs generate C-39 and 59-GCC CTG AAA GAA AGA GAT TAG G-39), or Y chromo-
chimeric embryos following the injection into blasto- somal±specific primers for sry (MuÈ ller et al., 1994) andYMT2/B (Med-
cysts. In contrast to earlier studies examining the pro- vinsky and Dzierzak, 1996) (59-CTG GAG CTC TAC AGT GAT GA-39
and 59-CAG TTA CCA ATC AAC ACA TCA C-39) in combination withduction of T cell subsets, which suggested that adult
myogenin-specific primers as internal PCR controls. The PCR cycleHSCs cannot produceprogeny with fetal features follow-
parameters for the combination lacZ/myogenin were 5 min at 948C,ing the exposure to a fetal environment, we show embry-
35 cycles of 608C for 30 s, 728C for 30 s, 958C for 20 s, followed by
onic-type globin gene expression in progeny of the adult 5 min at 728C; for the combination human b-globin/myogenin, 5 min
HSCs. In addition, transplantation of embryonic and fetal at 948C, 32 cycles of 578C for 30 s, 728C for 30 s, 958C for 10 s,
progenitor/stem cells into an adult environment results followed by 5 min at 728C; and for the combination YMT2/B/myo-
genin, 5 min at 948C, 32 cycles of 608C for 30 s, 728C for 35 s, 948Cin the activation of the adult globin transgenes but not
for 10 s, followed by 5 min at 728C. Sequences and cycle parameterstheembryonic/fetal transgenes, showing the dominance
specific for the myogenin and sry genes were as described (MuÈ llerof the microenvironment on the developmental stage±
et al., 1994). PCR products were separated in agarose gels, trans-
specific gene expression pattern. ferred to nylon membranes (Nytran), and hybridized to specific
32P-labeled probes. Sizes of PCR products are myogenin, 245 bp;
lacZ, 345 bp; human b-globin, 267 bp; YMT2/B, 342 bp; and sry,Experimental Procedures
441 bp.
Purification of Hematopoietic Stem Cells
HSCs were isolated according to (Okada et al., 1992). Bone marrow
Methylcellulose Culture Systemfrom tibia and femur of 6±21-week-old mice was flushed out and
HSCs from ROSAb-geo26 animals were injected into blastocystsred cells were lysed in Gey's solution. Bone marrow cells were
from strains BALB/c, NMRI or matings of Wv/1 animals. On E12.5,incubated with unconjugated rat antibodies Ter119 (anti-erythro-
single-cell suspensions of fetal liver cells and peripheral blood werecyte-specific antigen), RA3-6B2 (anti-B220), RB6-8C5 (anti-Gr-1),
seeded in a final volume of 1 ml methylcellulose mix supplementedM1/70 (anti-Mac-1), Gk1.5 (anti-CD4), and 53-6.72 (anti-CD8)
with 25 U/ml rmIL3, 1 U/ml rmEPO, and 2% PWM-SCCM in thespecific for lineage (Lin) markers, followed by the addition of goat
presence of 1 mg/ml G418. These culture conditions favor theanti-rat IgG-coupled immunomagnetic beads (Miltenyi). Lin1 cells
growth of myeloid cells. They are suboptimal for erythroid colonywere removed on a MACS column according to the manufacturer's
formation, and erythroid progenitor cells are more sensitive to G418protocol (Miltenyi). The Lin2 cell fraction was incubated with FITC-
than myeloid cells (data not shown). Furthermore, at the G418 con-conjugated ACK-4 (anti-c-kit) and PE-conjugated E13.161.7 (anti-
centration used, some endogenous colony activity is still observed.Sca-1, Pharmingen) antibodies and was further incubated with
Colonies were picked 16 days after seeding, lysed in 10 ml TE by 3biotin-conjugated rabbit-anti-goat antibody followed by Cy5-PE
min boiling, and assayed for the presence of the lacZ gene by PCR.(RED670)-conjugated streptavidin (Life Technologies) to deplete
residual Lin1 cells in the FACsort. Lin2, c-kit1, Sca-11 cells were
isolated on a Becton Dickinson FACsort.
CFU-S Analysis
The spleen colony assay was performed as described (Till and
Blastocyst Injection McCulloch, 1961). Tissues were isolated from human globin
HSCs were injected into blastocysts and implanted into foster moth- transgenic embryos and incubated in 0.1 U/ml collagenase/0.8 U/ml
ers using standard techniques and procedures (Bradley, 1987). dispase (Boehringer Mannheim) in 15% FCS/PBS for 2 hr. Bone
marrow cells of human globin transgenic mice were flushed from
femurs and tibia and a single cell suspension was produced, fol-Culture of Blastocysts after HSCs Injection
Injected blastocysts were cultured for 1 day in 50% mouse serum, lowed by red blood cell lysis. Embryonic cell suspensions and adult
bone marrow cells were injected intravenously into irradiated (2 325% egg-medium, 23% DMEM, 1024 M 2-mercaptoethanol, 2%
WEHI3 cell-conditioned medium (mIL3), 100 ng/ml rmSCF (Sigma), 400 rads of a Phillips X-ray tube source) C57BL/6 female recipients.
Irradiated animals were given autoclaved food and drinking waterand 20 ng/ml rhIL6 (Boehringer Mannheim). Blastocysts were then
treated with 0.1 U/ml collagenase/0.8 U/ml dispase (Boehringer supplemented with 0.16% Neomycin-sulfate. On the eighth and
eleventh day postinjection, individual spleen colonies were dis-Mannheim) supplemented with 15% FCS for 1 hr and seeded in a
final volume of 1 ml of methylcellulose (MethoCult M3100, Stem Cell sected out and total RNA was prepared. All animal handling was
done according to the animal protection guidelines of the Max-Technologies) containing 30% FCS, 1% BSA, 1024 M 2-mercapto-
ethanol, 100 ng/ml rmSCF (Sigma), 20 ng/ml rhIL6 (Boehringer Planck Institute.
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RNA Analysis S., and Akhurst, R.J. (1995). Defective haematopoiesis and vasculo-
genesis in transforming growth factor-beta 1 knock-out mice. Devel-Tissue RNAs were extracted with RNAzolB, and 500 ng of total RNA
was reverse transcribed into cDNA using M-MLV reverse tran- opment 121, 1845±1854.
scriptase (Life Technologies) and poly(T)NN primers in a reaction Dillon, N., and Grosveld, F. (1991). Human gamma-globin genes
volume of 20 ml under conditions recommended by the manufac- silenced independently of other genes in the beta-globin locus.
turer. To normalize the cDNA yields, the relative amount of cDNA Nature 350, 252±254.
synthesized was assayed by analyzing the hypoxanthine phosphori- Eglitis, M.A., and Mezey, E. (1997). Hematopoietic cells differentiate
bosyltransferase (HPRT) gene expression. HPRT-specific and hu- into both microglia and macroglia in the brains of adult mice. Proc.
man globin transgene±specific RT±PCR were done as described Natl. Acad. Sci. USA 94, 4080±4085.
(Keller et al., 1993; Bungert et al., 1995) in the presence of [33P]aATP
Faust, N., Huber, M.C., Sippel, A.E., and Bonifer, C. (1997). Different(Amersham). Concentration of PCR primers in a 40 ml PCR reaction
macrophage populations develop from embryonic/fetal and adultwere 30 ng each for human e-globin-specific primer, 10 ng each for
hematopoietic tissues. Exp. Hematol. 25, 432±444.human g-globin-specific primer, and 10 ng each for human b-globin-
Fleischman, R.A., and Mintz, B. (1984). Development of adult bonespecific primer. PCR reaction was carried out in 2.5 mM MgCl2 in
marrow stem cells in H-2-compatible and -incompatible mouse fe-the presence of all three human globin± specific primers. The reac-
tuses. J. Exp. Med. 159, 731±745.tion for the combination of human b-globin-specific oligonucleo-
tides involved initial heating at 948C for 5 min, followed by 35 cycles Fleischman, R.A., Custer, R.P., and Mintz, B. (1982). Totipotent he-
at 948C for 30 s, 588C for 30 s, 728C for 30 s, and 5 min at 728C. matopoietic stem cells: normal self-renewal and differentiation after
RT±PCR fragments were separated in 8% polyacrylamide gels. Sizes transplantation between mouse fetuses. Cell 30, 351±359.
of the RT±PCR products are 135 bp for human e-globin, 165 bp for Friedrich, G., and Soriano, P. (1991). Promoter traps in embryonic
human g-globin, 212 bp for human b-globin, and 248 for HPRT. With stem cells: a genetic screen to identify and mutate developmental
the exception of embryos number 54 and 57, embryos analyzed by genes in mice. Genes Dev. 5, 1513±1523.
RT±PCR were not pretested for chimerism on the DNA level and
Gardner, R.L., Lyon, M.F., Evans, E.P., and Burtenshaw, M.D. (1985).are not included in Table 1.
Clonal analysis of X-chromosome inactivation and the origin of the
germ line in the mouse embryo. J. Embryol. Exp. Morphol. 88,
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